Alternative promoters control UGT2B17dependent androgen catabolism in prostate cancer and its influence on progression

Alternative promoters control UGT2B17-dependent androgen catabolism in prostate cancer and its influence on progression

14:30 EST 12 Feb 2020 | Nature Publishing

More From BioPortfolio on "Alternative promoters control UGT2B17-dependent androgen catabolism in prostate cancer and its influence on progression"